Navigation Links
Consensus on "Combination Therapy" for Breast Cancer ,,

Breast cancer is the commonest cancer among women in the world. There has been some on going controversy on certain aspects of treatment modalities of this cancer. Besides surgery there are other options to treat the cancer including radiation, chemotherapy and hormonal therapy. Now at a three-day conference at the National Institutes of Health doctors have agreed to a consensus on the combination therapy for the cancer. Dctors have agreed that the combination therapy for women with breast cancer is beneficial. Depending on a woman's stage of the disease the experts recommend surgery along with either chemotherapy or hormonal therapy.



To help in the decision-making, experts came up with their own recommendations as follows:

1. Women whose breast tumors contain estrogen receptors, regardless of other factors, are recommended to use hormonal therapy. The panel suggests five years of drug-Tamoxifen as the standard hormonal adjuvant therapy. Hormonal therapy is not suggested for women whose tumors do not have hormone receptors.

2. Women who have had a mastectomy and have four or more cancerous lymph nodes can best benefit from post-surgical radiation. At this point the panel says there is not enough evidence that women with three or fewer cancerous lymph nodes benefit from radiation.

Patricia Eifel of Anderson Cancer Center in Houston, said to one of the medical news agencies that, "Women with breast cancer have more treatment options and a better chance of surviving their disease than ever before. At the same time, making treatment decisions has become a more complex process for them and their physicians due to a growing list of effective options."
'"/>




Page: 1

Related medicine news :

1. Climate Talks Reach Consensus in Bangkok
2. Women Alerted against "Natural Hormone Replacement Therapy"
3. Breast cancer treatment to be determined by gene test
4. Breast Feeding prevents obesity later on in life
5. Breast milk is essential
6. Breast Cancer Surgery Causes Psychological problems
7. Breast cancer evidence
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Breast screening among diabetic women
10. Breast feeding can alter hormones
11. Diet, Sunlight connected to Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: